Project Grant T32AI186973
Award Date 8/1/26
Completion Date 7/31/31
Dollars Obligated $202K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Houston, TX 77030, USA
Similar Awards
- The National Institute of Allergy and Infectious Diseases awarded Baylor College of Medicine $452,128 on September 1, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to support research training in infection and immunity. The award funds the Baylor College of Medicine Research Training in Infection and Immunity program, which will train four MD, MD/PhD, or PhD postdoctoral fellows annually for two years of mentored research training. The program provides a...
- The National Institute of Allergy and Infectious Diseases, a division of the Department of Health and Human Services, awarded the University of Maryland, Baltimore $312,537 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on September 1, 2026, to support the Mechanisms Integrating Nervous and Immune Systems Training Program (MINISTP). The award funds a two-tiered training curriculum designed to prepare three graduate students and two post-doctoral researchers for up to...
- The National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, awarded $504,547 to The Regents of the University of California, San Francisco (UCSF) on August 6, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855, Project Grant T32AI200899). The award funds the UCSF Immunology Training Program (ITP), which provides structured training to approximately 5–6 graduate students per year (3 per cohort) and 2–3...
- The National Institute of Allergy and Infectious Diseases awarded The University of Texas Southwestern Medical Center $249,000 on July 20, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award funds research to develop tools for marginal zone-specific gene expression manipulation in B cells. The project investigates how mature B cell subsets—follicular, marginal zone, and B-1 cells—contribute to protective immune responses in infection and pathogenic responses...
- The National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services National Institutes of Health, awarded the University of Oklahoma Health Sciences Center $233,001 on August 1, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to support an interdisciplinary training program in immunity and microbial infection. The award funds a five-year training program that will provide predoctoral research training to five trainees per...
- The National Institute of Allergy and Infectious Diseases awarded William Marsh Rice University $2,538,587 on July 8, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to investigate the molecular mechanisms by which ADAR1 (adenosine deaminase acting on RNA) regulates RNA-induced immune responses and modulates immunostimulatory pathways. The research dissects how ADAR1 recognizes and edits diverse immunostimulatory RNAs to modulate their structure and...
- The National Institute of Allergy and Infectious Diseases awarded Baylor College of Medicine $101,052 for basic research investigating the role of granzyme A in CD8 T cell exhaustion under the Allergy and Infectious Diseases Research program (CFDA 93.855) on October 16, 2026. The funded research examines how CD8 T cells—which directly kill virally infected and cancerous cells—lose effector function when chronically stimulated by persistent antigens in chronic viral infections and cancer. The...
- The National Institute of Allergy and Infectious Diseases awarded Baylor College of Medicine $752,172 on September 1, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct a mechanistic study of an RNA translocase via integrative multi-resolution approach. The research investigates how mycobacteria persist in the host by examining a conserved bifunctional RNA helicase and nuclease enzyme found across mycobacterium species. The enzyme is thought to promote...
- The National Institute of Allergy and Infectious Diseases awarded Baylor University $561,968 on July 7, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to investigate the role of microbial-derived indoles in controlling Fusobacterium nucleatum virulence and host immune responses. The research determines the metabolic pathways contributing to indole-3-aldehyde and indole-3-carboxylic acid production in the human gut microbiome using computational gene annotation,...
- The National Institute of Allergy and Infectious Diseases awarded William Marsh Rice University $422,698 on February 6, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to explore how the innate immune system shapes the adaptation of emergent and pre-emergent opportunistic pathogens. The research uses a high-throughput approach combining microfluidics, in vitro experimental evolution, and genomic and phenotypic characterization to investigate microbial emergence and...